Boehringer Ingelheim Pharmaceuticals, Inc

Boehringer Ingelheim Pharmaceuticals, Inc. is a global leader in the pharmaceutical industry, dedicated to researching, developing, and manufacturing innovative medicines that improve the health and quality of life for patients worldwide.

Founded in 1885, the company has a rich history of commitment to scientific excellence and patient care. With a strong focus on research and development, Boehringer Ingelheim invests heavily in discovering new therapies for diseases with high unmet medical needs.

The company operates in various therapeutic areas, including respiratory diseases, cardiovascular health, oncology, and immunology. Their portfolio includes both prescription medications and over-the-counter products, catering to a diverse range of health conditions.

Boehringer Ingelheim is also committed to sustainability and corporate social responsibility, striving to make a positive impact on society and the environment. They actively engage in initiatives that promote health education and access to healthcare services.

With a workforce of approximately 50,000 employees globally, the company fosters a culture of innovation and collaboration, encouraging its teams to push the boundaries of science and technology.

Headquartered in Ingelheim am Rhein, Germany, Boehringer Ingelheim has a significant presence in the UK, where it continues to expand its operations and contribute to the local economy.

The company’s vision is to create value through innovation, ensuring that they remain at the forefront of the pharmaceutical industry while maintaining a strong ethical foundation.

In summary, Boehringer Ingelheim Pharmaceuticals, Inc. is not just a pharmaceutical company; it is a partner in health, dedicated to making a difference in the lives of patients around the world.